var disqus_url = 'http://www.insidecosmeceuticals.com/news/2011/06/symrise-wins-two-bsb-awards.aspx';

Symrise Wins Two BSB Awards

Comments
Print

HOLZMINDEN, Germany—Symrise won two BSB awards. SymFinity® 1298 won a first price for its anti-aging properties. A second place went to SymPeptide® 226EL for its eyelash-growing effect.

Care and Beauty—These two fields belong to those cosmetic topics most cared about by people today. The BSB award is honoring ingredients that excel in these fields.

First place award winner, SymFinity®1298 best showcases the continued advancements within the anti-aging active ingredient sector. SymFinity 1298 is a 100-percent natural product with triple-action anti-aging benefits. Derived from Echinacea purpurea, the purple coneflower, SymFinity 1298 helps to prevent the appearance of irritation. It extends the youth of skin, combined with superior antioxidant support and complexion balancing benefits.

SymPeptide 226EL, received a second place award within the “Innovative Raw Materials- Natural/Actives" category. Through a collaborative partnership with Therapeutic Peptides Inc. located in the USA, Symrise was able to launch SymPeptide 226 EL. Several studies show SymPeptide 226EL delivers ultra, luscious eyelashes within two to four weeks when used as directed.

Dr. Marielle le Maire explained: “We are very proud to have achieved even two BSB awards this year—first and second place. It honors our extensive research efforts in the field of natural cosmetic ingredients and motivates us to further develop new ideas and concepts in this field. With the consumer looking for beauty from inside and outside we see plenty of potential for substances from other natural resources. This is where our expertise lies."

/**/ var loc = window.location.pathname;var nt=String(Math.random()).substr(2,10);document.write ('');

Sources:

/**/
Comments
//window.disqus_no_style = true; (function() { var SHORTNAME = 'insidecosmeceuticals'; // Your website's shortname on Disqus var dsq = document.createElement('gascript'); dsq.type = 'text/javagascript'; dsq.async = true; dsq.src = 'http://disqus.com/forums/' + SHORTNAME + '/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();
/**/
 
//= 0) { query += 'url' + i + '=' + encodeURIComponent(links[i].href) + '&'; } } document.write(''); })(); //]]> /* var pageTracker = _gat._getTracker("UA-624328-41"); pageTracker._setDomainName("auto"); pageTracker._trackPageview(); /*]]>*/